Three Repurposed Drugs Flop for Thwarting Severe COVID

(MedPage Today) -- Early treatment with three repurposed drugs -- metformin, ivermectin, or fluvoxamine -- did not prevent severe outcomes from COVID-19 in high-risk patients, according to a phase III randomized trial. Among over 1,300 patients...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news